Eindhoven, The Netherlands-based Microsure plans to use the funds to finalize the development of its newest microsurgical robot. It intends to progress its MUSA-3 robot through clinical studies, then subsequent FDA clearance and CE mark approval.
The company designed MUSA-3 to “revolutionize the field of open microsurgery,” according to a news release. It offers surgeons precision, stability and control beyond human capabilities, the company says. The system builds upon its previous generations — the MUSA-2 robot.
MUSA-3 offers enhanced dexterity, a wider workspace and tremor reduction for enhanced precision. It integrates seamlessly with surgeons’ existing preferred micro-instruments from different brands. The system’s adaptability also enables its us…